The president argued in his letter that the Republican plan carries costs that will rise exponentially, risking the extended solvency of the Medicare and Social Security plans, and the country's ability to pay down the national debt, among other fiscal priorities.
According to the companies, the FDA sent a complete response letter regarding the trial-stage drug Horizant, which is in the form of an extended-release pill taken to lessen pain caused by the condition.